4
Changes in Ownership
Acumen Pharmaceuticals, Inc. Filed Acc 0001576885-25-000021
Chief Executive Officer sold 47,778 shares at $1.84 ($87,873)
- Chief Executive Officer acquired 225,400 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| OConnell Daniel Joseph Chief Executive Officer | 2025-01-03 | Sale 10b5-1 | −47,778 | $1.84 | $87,873 | 454,707 | D |
| OConnell Daniel Joseph Chief Executive Officer | 2025-01-07 | Grant or award 10b5-1 | +225,400 | 680,107 | D | ||
| Derivatives | |||||||
| OConnell Daniel Joseph Chief Executive Officer | 2025-01-07 | Grant or award · Employee Stock Option (right to buy) 10b5-1 | +338,000 | 338,000 | D | ||
| Open-market sales · 47,778 sh · avg $1.84 · $87,873 | |||||||
Loading xslF345X05/wk-form4_1736298537.xml…